Gene: SLC9A5
Official Full Name: solute carrier family 9 member A5provided by HGNC
Gene Summary: Enables arrestin family protein binding activity and sodium:proton antiporter activity. Involved in regulation of intracellular pH and sodium ion transmembrane transport. Located in several cellular components, including focal adhesion; neuron spine; and recycling endosome membrane. Implicated in end stage renal disease. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03730 | SLC9A5 Knockout cell line (HCT 116) | Human | SLC9A5 | 1:2~1:4 | Negative | Online Inquiry |
KO03731 | SLC9A5 Knockout cell line (HEK293) | Human | SLC9A5 | 1:3~1:6 | Negative | Online Inquiry |
KO03732 | SLC9A5 Knockout cell line (A549) | Human | SLC9A5 | 1:3~1:4 | Negative | Online Inquiry |
SLC9A5 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone genetic modification to disrupt the SLC9A5 gene, which encodes the sodium/hydrogen exchanger 5 (NHE5). This exchanger plays a crucial role in regulating intracellular pH, cell volume, and sodium ion homeostasis. By creating knockout variants of these cell lines, researchers can investigate the physiological and pathological effects of SLC9A5 deficiency, enabling deeper insights into its role in various biological processes such as synaptic function, neuronal signaling, and cellular metabolism.
The knockout mechanism relies on advanced gene-editing technologies such as CRISPR/Cas9, allowing precise targeting and deletion of the SLC9A5 gene. The resulting cell lines exhibit altered ion transport dynamics and can serve as valuable tools for studying diseases linked to dysregulated ion homeostasis, including neurological disorders, cancer, and metabolic syndromes. In research settings, these cell lines facilitate the elucidation of SLC9A5's physiological roles and its potential implications in drug development and therapeutic interventions.
One of the significant advantages of SLC9A5 Gene Knockout Cell Lines is their ability to provide a controlled environment to assess the biological consequences of gene loss, which traditional models may not adequately reflect. They stand apart from alternatives by offering reproducibility, high-throughput screening capabilities, and the potential for co-culture experiments that mimic in vivo conditions closely.
For researchers, clinicians, and pharmaceutical scientists, SLC9A5 Gene Knockout Cell Lines represent a crucial asset for unraveling the complexities of cellular ion transport mechanisms and their impact on health and disease. Their applicability across various fields, including pharmacology and genetics, underscores their relevance in both academic and clinical investigations.
Our company has extensive expertise in the development of precision-engineered cell lines, making us a trusted partner in the realm of biological products. We are committed to providing high-quality models that accelerate the pace of research and innovation in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.